Skip to content

Study on the curative effect of Tiao Zhi Yang Sheng Cha in the treatment of dyslipidemia in ASCVD low-risk patients

Study on the curative effect of Tiao Zhi Yang Sheng Cha in the treatment of dyslipidemia in ASCVD low-risk patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001341
Enrollment
Unknown
Registered
2025-07-05
Start date
2025-03-15
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

Chinese Medicine treatment group:On the basis of routine guidance the patients were given Tiao Zhi Yang Sheng Cha. The patients were placed in hot water for soaking and drinking 1 package per day for
control group:Patients received dietary guidance exercise guidance etc. and did not take Tiao Zhi Yang Sheng Cha.

Sponsors

Affiliated Hospital of Jining Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients with primary hyperlipidemia and fasting lipid levels that meet one of the following criteria: 1) TC =5.2 mmol/L, 2) LDL-C =3.4 mmol/L, 3) TG =1.7 mmol/L, and 4) HDL-C <1.0 mmol/L. (2) ASCVD risk stratification for low-risk patients; (3) 18 years = age = 75 years, male and female;

Exclusion criteria

Exclusion criteria: (1) Those who have previously suffered from severe liver failure and serious primary diseases of the cardiovascular pulmonary renal and hematopoietic systems; (2) Pre-existing conditions that affect dyslipidemia such as diabetes nephrotic syndrome and hypothyroidism; (3) Those who have a history of mental illness or other serious medical conditions that in the judgment of the investigator make them unsuitable for participation in this study; (4) Those who have applied lipid-lowering drugs in the past or those who are allergic to the ingredients of this Chinese medicine; (5) Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
LDL-C;TC;HDL-C;TG;

Secondary

MeasureTime frame
LP(a);body composition analysis;Chinese Medicine Symptom Scale;

Countries

China

Contacts

Public ContactLi Jiali

Affiliated Hospital of Jining Medical University

lijiali5678@163.com18653725797

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026